1. Home
  2. FAF vs KRYS Comparison

FAF vs KRYS Comparison

Compare FAF & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First American Corporation (New)

FAF

First American Corporation (New)

HOLD

Current Price

$68.19

Market Cap

7.2B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$298.90

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAF
KRYS
Founded
1889
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.8B
IPO Year
2009
2017

Fundamental Metrics

Financial Performance
Metric
FAF
KRYS
Price
$68.19
$298.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$82.50
$297.60
AVG Volume (30 Days)
748.1K
273.5K
Earning Date
04-22-2026
05-04-2026
Dividend Yield
3.09%
N/A
EPS Growth
376.19
128.00
EPS
1.21
1.83
Revenue
$7,452,200,000.00
$389,130,000.00
Revenue This Year
$7.85
$38.74
Revenue Next Year
$5.57
$32.53
P/E Ratio
$55.99
$166.58
Revenue Growth
21.61
33.94
52 Week Low
$53.95
$123.03
52 Week High
$71.47
$319.48

Technical Indicators

Market Signals
Indicator
FAF
KRYS
Relative Strength Index (RSI) 52.48 55.98
Support Level $64.27 $253.89
Resistance Level $71.35 $319.48
Average True Range (ATR) 1.74 11.79
MACD -0.30 -0.87
Stochastic Oscillator 37.75 46.86

Price Performance

Historical Comparison
FAF
KRYS

About FAF First American Corporation (New)

First American Financial Corp is engaged in the business of providing title insurance, settlement services, and other financial services and risk solutions. The group's reportable segments are: Title insurance and services, Home warranty, and Corporate. Maximum revenue is generated from the Title insurance and services segment, which provides title insurance, closing, escrow, and related services domestically and internationally in connection with residential and commercial real estate transactions. This segment also provides solutions to mitigate risk and facilitate real estate transactions, along with offering banking, trust, warehouse lending, mortgage subservicing and wealth management services. The majority of the group's revenue is generated from escrow fees and insurance premiums.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: